Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilma Knol

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Health and Quality of Life Outcomes|September 30, 2020
Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacyArjun Bhadhuri, Paul Kind, Paola Salari, et al.
European Geriatric Medicine|June 10, 2026
Response to Boland et al. "Appraisal of the references supporting STOPP/START version 3 criteria"Denis O'Mahony, Antonio Cherubini, Anna Renom Guiteras, et al.
European Geriatric Medicine|October 11, 2023
Authors' response to points raised by Boland et al. regarding STOPP/START version 3 criteriaDenis O'Mahony, Antonio Cherubini, Anna Renom Guiteras, et al.
European Journal of Pharmacology|January 11, 2025
The impact of summative, formative or programmatic assessment on the Dutch National Pharmacotherapy assessment: A retrospective multicentre studyErik M Donker, Floor van Rosse, Ben J A Janssen, et al.
European Geriatric Medicine|February 28, 2024
Response to letter by Masse O et al. STOPP/START version 3: clinical pharmacists are raising alarmsDenis O'Mahony, Antonio Cherubini, Anna Renom Guiteras, et al.
BMC Geriatrics|July 19, 2025
Inappropriate vitamin D supplementation among multimorbid older patients: a multicountry analysisElisavet Moutzouri, Shanthi Beglinger, Martin Feller, et al.
Journal of Clinical Medicine|October 29, 2025
Association Between Hyponatremia and Mortality and Readmission in Multimorbid Older Adults-A Cohort StudySeraina Netzer, Viktoria Gastens, Benoît Boland, et al.
European Geriatric Medicine|May 31, 2023
STOPP/START criteria for potentially inappropriate prescribing in older people: version 3Denis O'Mahony, Antonio Cherubini, Anna Renom Guiteras, et al.
European Geriatric Medicine|June 20, 2022
Polypharmacy, comorbidity and frailty: a complex interplay in older patients at the emergency departmentCarmen S van Dam, Helena A Labuschagne, Kris van Keulen, et al.
Journal of the American Geriatrics Society|April 1, 2025
Impact of Discontinuation of Fall-Risk-Increasing Drugs on Falls in Multimorbid Older Patients With PolypharmacyNamiko A Goto, Dayna A M van Heel, Lauren Dautzenberg, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Health and Quality of Life Outcomes|September 30, 2020
Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacyArjun Bhadhuri, Paul Kind, Paola Salari, et al.
European Geriatric Medicine|June 10, 2026
Response to Boland et al. "Appraisal of the references supporting STOPP/START version 3 criteria"Denis O'Mahony, Antonio Cherubini, Anna Renom Guiteras, et al.
European Geriatric Medicine|October 11, 2023
Authors' response to points raised by Boland et al. regarding STOPP/START version 3 criteriaDenis O'Mahony, Antonio Cherubini, Anna Renom Guiteras, et al.
European Journal of Pharmacology|January 11, 2025
The impact of summative, formative or programmatic assessment on the Dutch National Pharmacotherapy assessment: A retrospective multicentre studyErik M Donker, Floor van Rosse, Ben J A Janssen, et al.
European Geriatric Medicine|February 28, 2024
Response to letter by Masse O et al. STOPP/START version 3: clinical pharmacists are raising alarmsDenis O'Mahony, Antonio Cherubini, Anna Renom Guiteras, et al.
BMC Geriatrics|July 19, 2025
Inappropriate vitamin D supplementation among multimorbid older patients: a multicountry analysisElisavet Moutzouri, Shanthi Beglinger, Martin Feller, et al.
Journal of Clinical Medicine|October 29, 2025
Association Between Hyponatremia and Mortality and Readmission in Multimorbid Older Adults-A Cohort StudySeraina Netzer, Viktoria Gastens, Benoît Boland, et al.
European Geriatric Medicine|May 31, 2023
STOPP/START criteria for potentially inappropriate prescribing in older people: version 3Denis O'Mahony, Antonio Cherubini, Anna Renom Guiteras, et al.
European Geriatric Medicine|June 20, 2022
Polypharmacy, comorbidity and frailty: a complex interplay in older patients at the emergency departmentCarmen S van Dam, Helena A Labuschagne, Kris van Keulen, et al.
Journal of the American Geriatrics Society|April 1, 2025
Impact of Discontinuation of Fall-Risk-Increasing Drugs on Falls in Multimorbid Older Patients With PolypharmacyNamiko A Goto, Dayna A M van Heel, Lauren Dautzenberg, et al.
Pageof 10